DIRECT TO LUNGS
What is TYVASO?
TYVASO is a direct-to-the-lungs, inhaled prostacyclin mimetic indicated for the treatment of pulmonary hypertension associated with interstitial lung disease (PH-ILD; WHO Group 3).1
TYVASO treats at the site of disease1,2
TYVASO is inhaled directly to distal airspaces that are in close proximity to pulmonary arterioles affected by pulmonary hypertension.3
Direct-to-lung delivery results in higher concentrations in the pulmonary arterial vasculature, which may selectively enhance blood flow for better ventilation and perfusion matching with less off-target exposure.2
TYVASO has 2 delivery device options:
-
An ultrasonic nebulizer, which is not dependent on your patient’s lung capacity1,4
-
A dry powder inhaler, which does not require a strong breath5,6
WHO=World Health Organization.
TYVASO DPI®
THE PROVEN EFFICACY OF TYVASO®
IN THE PALM OF YOUR HAND1,2
TYVASO DPI Inhalation Powder is a simple-to-use, inhaled prostacyclin therapy that delivers the trusted safety and benefits of TYVASO.1,2
Get the details about TYVASO DPI.
DPI=dry powder inhaler.
References: 1. TYVASO DPI [package insert]. Research Triangle Park, NC: United Therapeutics Corporation; 2022. 2. Spikes LA, Bajwa AA, Burger CD, et al. BREEZE: open-label clinical study to evaluate the safety and tolerability of treprostinil inhalation powder as Tyvaso DPI™ in patients with pulmonary arterial hypertension. Pulm Circ. 2022;12:e12063. doi:10.1002/pul2.12063.
This referral form has recently been revised to include TYVASO DPI™ (treprostinil) Inhalation Powder, a new dry powder inhaler option for your patients.
Currently, the 48 mcg (112 ct) and 64 mcg (112 ct) Maintenance Kits (28-day supply) are available for ordering. These strengths correspond with 8-10 breaths and 11-12 breaths with the TYVASO nebulizer, respectively. The remaining Maintenance Kits and Titration Kits will be available soon.
To learn more about TYVASO DPI and Kit availability, please reach out to your local United Therapeutics Cardiopulmonary Specialist.
The information contained in this section of the site is clinical in nature and specifically created for healthcare professionals. If you are not a US healthcare professional, please click CLOSE to return to the consumer section of the site.
YOU ARE NOW LEAVING THE TYVASO WEBSITE
This link will take you to a site maintained by a third party who is solely responsible for the site’s content. Click CONTINUE to proceed or CLOSE to return to www.TYVASOhcp.com.
The information contained in this section of the site is clinical in nature and specifically created for healthcare professionals. If you are not a US healthcare professional, please click CLOSE to return to the consumer section of the site.